Charles River Laboratories International (CRL) has acquired privately held Tacoma, WA-based Northwest Kinetics for $29.5 million dollars. The acquisition establishes a Phase I clinical services capacity for CRL in North America, which in conjunction with its Phase I facility in Edinburgh, Scotland, positions the company to support its clients’ clinical pharmacology studies and further expands CRL’s role in preclinical and early clinical development. Northwest Kinetics is a 150-bed...